Olema Pharmaceuticals, Inc. (OLMA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.87 | +15.0% |
| 2024 | $-2.20 | -2.8% |
| 2023 | $-2.14 | +18.3% |
| 2022 | $-2.62 | -45.6% |
| 2021 | $-1.80 | +47.4% |
| 2020 | $-3.42 | -106.0% |
| 2019 | $-1.66 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.87 | +15.0% |
| 2024 | $-2.20 | -2.8% |
| 2023 | $-2.14 | +18.3% |
| 2022 | $-2.62 | -45.6% |
| 2021 | $-1.80 | +47.4% |
| 2020 | $-3.42 | -106.0% |
| 2019 | $-1.66 | — |